Provided by Tiger Trade Technology Pte. Ltd.

Catalyst Pharmaceuticals

23.40
-0.8500-3.51%
Post-market: 23.400.00000.00%19:53 EDT
Volume:754.84K
Turnover:17.82M
Market Cap:2.86B
PE:13.93
High:24.29
Open:24.15
Low:23.39
Close:24.25
52wk High:26.58
52wk Low:19.05
Shares:122.12M
Float Shares:115.02M
Volume Ratio:0.51
T/O Rate:0.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.68
EPS(LYR):1.68
ROE:25.49%
ROA:16.48%
PB:2.99
PE(LYR):13.93

Loading ...

Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Feb 26

Earnings Flash (CPRX) Catalyst Pharmaceuticals Posts Q4 Adjusted EPS $0.68, vs. FactSet Est of $0.59

MT Newswires Live
·
Feb 26

Catalyst Pharmaceuticals Q4 Adj. EPS $0.68 Beats $0.34 Estimate, Sales $152.502M Beat $142.034M Estimate

Benzinga
·
Feb 26

BRIEF-Catalyst Pharmaceuticals FY Revenue USD 589 Million Vs. IBES Estimate USD 578.4 Million

Reuters
·
Feb 26

Catalyst Pharmaceuticals FY Operating Income USD 257.8 Million

THOMSON REUTERS
·
Feb 26

Catalyst Pharmaceuticals Reports Record Fourth Quarter and Record Full Year 2025 Financial Results and Provides 2026 Financial Guidance

GlobeNewswire
·
Feb 26

Analysts Conflicted on These Healthcare Names: Catalyst Pharma (CPRX), Vaxcyte (PCVX) and Acadia Healthcare (ACHC)

TIPRANKS
·
Feb 25

Catalyst Pharmaceuticals to Participate in Barclays 28th Annual Global Healthcare Conference

Reuters
·
Feb 24

Catalyst Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Feb 19

Earning Preview: Catalyst Pharmaceuticals Q4 revenue is expected to increase by 5.84%, and institutional views are broadly constructive

Earnings Agent
·
Feb 18

Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Feb 18

Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Feb 14

Catalyst Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Feb 12

Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026

GlobeNewswire
·
Feb 11

Assessing Catalyst Pharmaceuticals (CPRX) Valuation After Renewed Interest And Pocket Pivot Signal

Simply Wall St.
·
Feb 11

Catalyst Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Feb 06

Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Feb 03

Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jan 30

Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jan 27

Catalyst Pharmaceuticals Inc. Stock Falls 3.6%, Underperforms Peers

Dow Jones
·
Jan 24